Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 35% ± 15% | |
respiratory goblet cell | 5 studies | 38% ± 11% | |
secretory cell | 5 studies | 25% ± 12% | |
epithelial cell of proximal tubule | 5 studies | 29% ± 8% | |
hepatocyte | 5 studies | 60% ± 15% | |
ciliated cell | 4 studies | 25% ± 6% | |
luminal cell of prostate epithelium | 4 studies | 45% ± 6% | |
basal cell | 3 studies | 31% ± 11% | |
club cell | 3 studies | 27% ± 3% | |
intestinal crypt stem cell | 3 studies | 18% ± 2% | |
erythroblast | 3 studies | 26% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 5 studies | 29% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 14775.80 | 244 / 245 | 100% | 108.94 | 501 / 502 |
liver | 100% | 10244.02 | 226 / 226 | 93% | 34.42 | 377 / 406 |
thymus | 100% | 12782.02 | 653 / 653 | 87% | 39.88 | 525 / 605 |
stomach | 97% | 1015.60 | 349 / 359 | 88% | 11.21 | 251 / 286 |
intestine | 86% | 494.39 | 829 / 966 | 94% | 12.52 | 494 / 527 |
bladder | 95% | 720.86 | 20 / 21 | 84% | 9.60 | 424 / 504 |
breast | 79% | 864.15 | 361 / 459 | 89% | 16.11 | 999 / 1118 |
skin | 100% | 1777.10 | 1804 / 1809 | 66% | 5.65 | 312 / 472 |
uterus | 91% | 475.67 | 154 / 170 | 75% | 7.56 | 345 / 459 |
brain | 87% | 495.67 | 2293 / 2642 | 78% | 6.14 | 552 / 705 |
pancreas | 92% | 479.27 | 302 / 328 | 72% | 5.78 | 129 / 178 |
esophagus | 70% | 679.49 | 1014 / 1445 | 89% | 10.47 | 162 / 183 |
ovary | 80% | 322.48 | 144 / 180 | 78% | 6.25 | 335 / 430 |
lung | 70% | 329.93 | 406 / 578 | 76% | 7.72 | 874 / 1155 |
kidney | 100% | 3341.12 | 89 / 89 | 40% | 2.96 | 359 / 901 |
adrenal gland | 100% | 2361.20 | 258 / 258 | 20% | 1.38 | 47 / 230 |
eye | 0% | 0 | 0 / 0 | 89% | 10.04 | 71 / 80 |
tonsil | 0% | 0 | 0 / 0 | 84% | 8.26 | 38 / 45 |
spleen | 83% | 342.22 | 199 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 76% | 339.68 | 1016 / 1335 | 0% | 0 | 0 / 0 |
heart | 67% | 304.16 | 577 / 861 | 0% | 0 | 0 / 0 |
adipose | 67% | 266.16 | 806 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 62% | 571.36 | 579 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 1.23 | 6 / 29 |
muscle | 19% | 62.55 | 153 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051160 | Biological process | L-xylitol catabolic process |
GO_0051164 | Biological process | L-xylitol metabolic process |
GO_0019640 | Biological process | glucuronate catabolic process to xylulose 5-phosphate |
GO_0030317 | Biological process | flagellated sperm motility |
GO_0006062 | Biological process | sorbitol catabolic process |
GO_0006006 | Biological process | glucose metabolic process |
GO_0046370 | Biological process | fructose biosynthetic process |
GO_0005615 | Cellular component | extracellular space |
GO_0016020 | Cellular component | membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0031514 | Cellular component | motile cilium |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0047833 | Molecular function | D-sorbitol dehydrogenase (acceptor) activity |
GO_0046526 | Molecular function | D-xylulose reductase activity |
GO_0051287 | Molecular function | NAD binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0050255 | Molecular function | ribitol 2-dehydrogenase (NAD+) activity |
GO_0003939 | Molecular function | L-iditol 2-dehydrogenase (NAD+) activity |
GO_0000721 | Molecular function | (R,R)-butanediol dehydrogenase activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | SORD |
Protein name | Sorbitol dehydrogenase (SDH) (XDH) (EC 1.1.1.14) (EC 1.1.1.9) (L-iditol 2-dehydrogenase) (Polyol dehydrogenase) (Xylitol dehydrogenase) Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) ((R,R)-butanediol dehydrogenase) (EC 1.1.1.4) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9) Sorbitol dehydrogenase Sorbitol dehydrogenase (EC 1.1.1.14) (EC 1.1.1.9) (L-iditol 2-dehydrogenase) (Polyol dehydrogenase) (Xylitol dehydrogenase) |
Synonyms | |
Description | FUNCTION: Polyol dehydrogenase that catalyzes the reversible NAD(+)-dependent oxidation of various sugar alcohols. Is mostly active with D-sorbitol (D-glucitol), L-threitol, xylitol and ribitol as substrates, leading to the C2-oxidized products D-fructose, L-erythrulose, D-xylulose, and D-ribulose, respectively . Is a key enzyme in the polyol pathway that interconverts glucose and fructose via sorbitol, which constitutes an important alternate route for glucose metabolism. The polyol pathway is believed to be involved in the etiology of diabetic complications, such as diabetic neuropathy and retinopathy, induced by hyperglycemia . May play a role in sperm motility by using sorbitol as an alternative energy source for sperm motility . May have a more general function in the metabolism of secondary alcohols since it also catalyzes the stereospecific oxidation of (2R,3R)-2,3-butanediol. To a lesser extent, can also oxidize L-arabinitol, galactitol and D-mannitol and glycerol in vitro. Oxidizes neither ethanol nor other primary alcohols. Cannot use NADP(+) as the electron acceptor . . FUNCTION: Polyol dehydrogenase that catalyzes the reversible NAD(+)-dependent oxidation of various sugar alcohols. Is active with D-sorbitol (D-glucitol) leading to the C2-oxidized product D-fructose. Is a key enzyme in the polyol pathway that interconverts glucose and fructose via sorbitol, which constitutes an important alternate route for glucose metabolism. May play a role in sperm motility by using sorbitol as an alternative energy source for sperm motility. . |
Accessions | ENST00000674387.1 Q00796 A0A6I8PIS1 ENST00000558789.5 [Q00796-2] ENST00000674211.1 ENST00000674405.1 A0A6I8PRA7 ENST00000559230.5 ENST00000267814.14 [Q00796-1] H0YKB3 |